Cargando…

Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection

BACKGROUND: Because of the late clinical presentation of biliary tract cancer (BTC), only 10% of patients are eligible for curative surgery. Even among those patients who have undergone curative surgery, most patients develop recurrent cancer. This study is to determine the clinical role of (18)F-FD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yun-Gyoo, Han, Sae-Won, Oh, Do-Youn, Chie, Eui Kyu, Jang, Jin-Young, Im, Seock-Ah, Kim, Tae-You, Kim, Sun-Whe, Ha, Sung Whan, Bang, Yung-Jue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120804/ https://www.ncbi.nlm.nih.gov/pubmed/21599995 http://dx.doi.org/10.1186/1471-2407-11-188

Ejemplares similares

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study
por: Lim, Kyu-Hyoung, et al.
Publicado: (2009)

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer
por: Ha, Hye rim, et al.
Publicado: (2016)

Detecting the Recurrence of Gastric Cancer after Curative Resection: Comparison of FDG PET/CT and Contrast-Enhanced Abdominal CT
por: Kim, Dae-Weung, et al.
Publicado: (2011)

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
por: Keam, Bhumsuk, et al.
Publicado: (2011)

A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions
por: Kim, Tae-Yong, et al.
Publicado: (2014)

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma
por: Kim, Byoung Hyuck, et al.
Publicado: (2015)

Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
por: Adams, Hugo J. A., et al.
Publicado: (2016)

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
por: Kim, Suzy, et al.
Publicado: (2011)

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study
por: Choi, Younak, et al.
Publicado: (2016)

Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy
por: Cho, Kyoung-Min, et al.
Publicado: (2017)

The role of PET/CT in detection of gastric cancer recurrence
por: Sim, Sung Hoon, et al.
Publicado: (2009)

FDG PET/CT Findings in Biliary Papillomatosis
por: Tu, Zhuolong, et al.
Publicado: (2020)

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
por: Lee, Kyung-Hun, et al.
Publicado: (2021)

Therapeutic implication of HER2 in advanced biliary tract cancer
por: Nam, Ah-Rong, et al.
Publicado: (2016)

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer
por: Cho, Kyoung-Min, et al.
Publicado: (2016)

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2016)

Postoperative chemoradiotherapy in high risk locally advanced gastric cancer
por: Song, Sanghyuk, et al.
Publicado: (2012)

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
por: Kim, Mi-Jung, et al.
Publicado: (2008)

FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients
por: Setti, Lucia, et al.
Publicado: (2020)

Is There Any Additional Benefit of Contrast-Enhanced CT as Part of Routine PET/CT Protocols for the Differentiation of Suspicious Incidental Gastrointestinal 2-Deoxy-(18)F-FDG Uptake?
por: Brendle, Cornelia Bettina, et al.
Publicado: (2013)

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer
por: Baek, Sun Kyung, et al.
Publicado: (2011)

Role of (18)F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis
por: Park, Soo Bin, et al.
Publicado: (2018)

NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations
por: PARK, EUNJU, et al.
Publicado: (2011)

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
por: Lee, Hwanhee, et al.
Publicado: (2023)

Prognostic Value of p53 and bcl-2 Expression in Patients Treated with Breast Conservative Therapy
por: Kim, Kyubo, et al.
Publicado: (2010)

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2017)

Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution
por: Kim, Byoung Hyuck, et al.
Publicado: (2017)

Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer
por: Im, Hyung-Jun, et al.
Publicado: (2016)

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
por: Choi, Younak, et al.
Publicado: (2016)

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
por: Choi, Younak, et al.
Publicado: (2015)

Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
por: Kim, Byoung Hyuck, et al.
Publicado: (2017)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
por: Lee, Kyung-Hun, et al.
Publicado: (2007)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery
por: Lee, Hyunjong, et al.
Publicado: (2023)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
por: Yoon, Ja Kyung, et al.
Publicado: (2022)

Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours
por: Albazaz, Raneem, et al.
Publicado: (2013)

More Accurate Prediction of Metastatic Pancreatic Cancer Patients’ Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity
por: Choi, Younak, et al.
Publicado: (2016)

Primary Biliary Lymphoma Mimicking Cholangiocarcinoma: A Characteristic Feature of Discrepant CT and Direct Cholangiography Findings
por: Yoon, Min A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0m5aou3ja4970g3ffbog6raejm